The prospective, randomized, multi-center, patient-blinded clinical trial evaluated rectal and urinary toxicity and QOL impact on prostate radiotherapy patients treated either with SpaceOAR hydrogel, ...
WALTHAM, Mass.--(BUSINESS WIRE)--Today Augmenix, Inc. (http://www.spaceoar.com/), a medical technology company that develops, manufactures, and sells proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback